Suchergebnisse - "Coutre, Steven E"

PubPharm (100)

1

Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL : updated results of the E1912 trial

enthalten in: Blood | 2022

von Shanafelt, T. | Wang, X. | Hanson, C. | +19

CommentIn: Blood. 2022 Jul 14;140(2):80-81. - PMID 35834283

2

Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection : Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study

enthalten in: Open forum infectious diseases | 2022

von Coutre, S. | Barnett, C. | Osiyemi, O. | +9

3

Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib

enthalten in: Blood | 2021

von Wang, X. | Hanson, C. | Tschumper, R. | +19

CommentIn: Blood. 2021 Dec 30;138(26):2746-2747. - PMID 34967869

4

Routine use of gemtuzumab ozogamicin in 7 + 3-based inductions for all 'non-adverse' risk AML

enthalten in: Leukemia & lymphoma | 2021

von Ladha, A. | Hui, G. | Cheung, E. | +7

5

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

enthalten in: Haematologica | 2020

von Ghia, P. | Coutre, S. | Cheson, B. | +7

6

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia : Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Byrd, J. | Furman, R. | Coutre, S. | +11

7

A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)

enthalten in: Blood advances | 2020

von Lancet, J. | Moseley, A. | Coutre, S. | +7

8

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL : 5 years of follow-up from the phase 3 RESONATE-2 study

enthalten in: Leukemia | 2020

von Burger, J. | Barr, P. | Robak, T. | +16

9

Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy

enthalten in: Haematologica | 2019

von Mato, A. | Wierda, W. | Davids, M. | +13

10

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia

enthalten in: Clinical lymphoma, myeloma & leukemia | 2019

von Kipps, T. | Fraser, G. | Coutre, S. | +23

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]